X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
asthma (17) 17
index medicus (12) 12
humans (10) 10
patients (8) 8
allergy (7) 7
allergy and immunology (7) 7
studies (7) 7
female (6) 6
immunology (6) 6
leukocytes (6) 6
mepolizumab (6) 6
asthma - drug therapy (5) 5
exacerbations (5) 5
medical research (5) 5
medicine, experimental (5) 5
respiratory function (5) 5
respiratory system (5) 5
analysis (4) 4
antibodies, monoclonal, humanized - therapeutic use (4) 4
care and treatment (4) 4
lungs (4) 4
male (4) 4
middle aged (4) 4
omalizumab (4) 4
severe asthma (4) 4
severe eosinophilic asthma (4) 4
abridged index medicus (3) 3
adult (3) 3
aged (3) 3
anti-asthmatic agents - therapeutic use (3) 3
asthma - pathology (3) 3
blood (3) 3
clinical trials (3) 3
data processing (3) 3
disease (3) 3
double-blind (3) 3
dream (3) 3
hospitalization (3) 3
oncology (3) 3
persistent asthma (3) 3
phenotypes (3) 3
population (3) 3
therapy (3) 3
adolescent (2) 2
anti-asthmatic agents - adverse effects (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antibody (2) 2
benralizumab (2) 2
breast cancer (2) 2
child (2) 2
comparative analysis (2) 2
corticosteroids (2) 2
count (2) 2
disease progression (2) 2
double-blind method (2) 2
efficacy (2) 2
eosinophils - pathology (2) 2
eq-5d (2) 2
heterogeneity (2) 2
leukocyte count (2) 2
licenses (2) 2
lung function (2) 2
medical colleges (2) 2
multicenter (2) 2
omalizumab - therapeutic use (2) 2
pharmacogenetics (2) 2
pulmonary eosinophilia - drug therapy (2) 2
pulmonary/respiratory (2) 2
quality of life (2) 2
research (2) 2
reslizumab (2) 2
respiratory agents (2) 2
risk factors (2) 2
treatment outcome (2) 2
trial (2) 2
young adult (2) 2
aged, 80 and over (1) 1
air-flow obstruction (1) 1
allergens (1) 1
allergic reaction (1) 1
allergic rhinitis (1) 1
allergic-asthma (1) 1
allergies (1) 1
am pef (1) 1
anti il-5 (1) 1
anti-asthmatic agents - administration & dosage (1) 1
anti-il-5 (1) 1
antiasthmatic agents (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
anticarcinogenic agents - administration & dosage (1) 1
anti–il-5 (1) 1
asthma - blood (1) 1
asthma - diagnosis (1) 1
asthma - immunology (1) 1
asthma - physiopathology (1) 1
binomial distribution (1) 1
biomarkers (1) 1
blood eosinophils (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - epidemiology (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2015, Volume 136, Issue 3, pp. 825 - 826
[...]personalized medicine should not be solely based on a biomarker but rather should be used in conjunction with careful characterization of the patient's... 
Allergy and Immunology | ALLERGY | MEPOLIZUMAB | IMMUNOLOGY | Asthma - diagnosis | Eosinophilia - pathology | Eosinophils - pathology | Asthma - pathology | Humans | Eosinophilia - diagnosis | Medicine, Experimental | Medical research | Asthma | Biomarkers | Population | Precision medicine | Patients | Blood
Journal Article
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB9 - AB9
Methods A meta-analysis of two randomized, double-blind, placebo-controlled studies (N=1192; MEA112997/MEA115588) with mepolizumab or placebo plus standard of... 
Allergy and Immunology | Asthma
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 139, Issue 2, pp. AB96 - AB96
Rationale Corticosteroid-dependent patients are concerned with drug-related complications associated with long term oral corticosteroid (OCS) treatment. 
Allergy and Immunology | Complications and side effects | Care and treatment | Corticosteroids | Asthma | Patients
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 2, pp. AB208 - AB208
Methods A meta-analysis (GSK ID 204664) of two randomized, double-blind placebo-controlled studies (MEA112997/MEA115588) with mepolizumab or placebo plus... 
Allergy and Immunology | Medical colleges | Pharmacogenetics | Franchises | Asthma
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 2, pp. AB103 - AB103
Methods This cross-sectional, single-visit, non-drug interventional study in 6 countries included subjects aged >=12 years with severe asthma defined according... 
Allergy and Immunology | Medicine, Experimental | Medical research | Epidemiology | Asthma
Journal Article
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2016, Volume 137, Issue 2, pp. AB82 - AB82
Included studies were double-blind randomized controlled clinical trials (RCTs) >=12 weeks' in duration among severe asthma patients >=12 years old, with a... 
Allergy and Immunology | Comparative analysis | Asthma
Journal Article
Chest, ISSN 0012-3692, 10/2018, Volume 154, Issue 4, pp. 769A - 769A
Journal Article
The Journal of Allergy and Clinical Immunology, ISSN 0091-6749, 02/2018, Volume 141, Issue 2, pp. AB16 - AB16
Methods Post-hoc analysis of data from two randomized, double-blind, placebo-controlled studies (NCT01691521/NCT02281318) of 4-weekly mepolizumab 100 mg... 
Studies | Respiratory function | Lungs | Leukocytes (eosinophilic) | Asthma
Journal Article
The Journal of asthma : official journal of the Association for the Care of Asthma, ISSN 0277-0903, 01/2020, pp. 1 - 12
Severe asthma (SA) can be uncontrolled despite guideline-directed treatment. We described SA characteristics and identified factors associated with... 
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 05/2018, Volume 6, Issue 3, pp. 980 - 986.e1
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 11/2014, Volume 106, Issue 11, p. 1
  Genome-wide association studies (GWAS) have identified hundreds of genetic susceptibility loci for cancers and other complex diseases. However, the public... 
Disease prevention | Genetics | Breast cancer | Environmental impact | Risk factors
Journal Article
Value in Health, ISSN 1098-3015, 2018
Objectives: To compare a generic versus disease-specific measure of health-related quality of life in terms of their psychometric properties and influence on... 
EQ-5D | ICER | utility | quality of life
Journal Article
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 05/2018, Volume 6, Issue 3, pp. 874 - 882.e4
Mepolizumab significantly reduces exacerbations in patients with severe eosinophilic asthma. The early identification of patients likely to receive long-term... 
Response | Continuation | Anti–IL-5 | Severe asthma | mAb | OMALIZUMAB | DREAM | LUNG-FUNCTION | PERSISTENT ASTHMA | IMMUNOLOGY | Anti IL-5 | ALLERGY | ALLERGIC-ASTHMA | EXACERBATIONS | COUNT | Studies | Respiratory function | Leukocytes (eosinophilic) | Resource allocation | Data processing | Patients | Methods | Blood | Asthma
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.